Targeting the tumor stroma in hepatocellular carcinoma

doi:10.4254/wjh.v7.i2.165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13011)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

696

WORD

317

HTML

7187

Figures (1-2)

224

Tables (1-1)

155

Sum=8579

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

649

Download

1062

Sum=1711

Publishing Process of This Article

Item

Count

Browse

1306

Download

1415

Sum=2721

Feb 27, 2015 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (55)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Feb 27, 2015; 7(2): 165-176
Published online Feb 27, 2015. doi: 10.4254/wjh.v7.i2.165

Full Size Figure Download Figure

Figure 2 Schematic overview of (simplified) signaling pathways involved in the tumor-stroma interaction, and therapeutic targets that are currently tested in hepatocellular carcinoma. IL: Interleukin; TGF: Transforming growth factor; mTOR: Mammalian target of rapamycin.

Citation: Heindryckx F, Gerwins P. Targeting the tumor stroma in hepatocellular carcinoma. World J Hepatol 2015; 7(2): 165-176
URL: https://www.wjgnet.com/1948-5182/full/v7/i2/165.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i2.165